Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain.
about
Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Cost-Minimisation Analysis of ...... nt for Schizophrenia in Spain.
@en
Cost-Minimisation Analysis of ...... nt for Schizophrenia in Spain.
@nl
type
label
Cost-Minimisation Analysis of ...... nt for Schizophrenia in Spain.
@en
Cost-Minimisation Analysis of ...... nt for Schizophrenia in Spain.
@nl
prefLabel
Cost-Minimisation Analysis of ...... nt for Schizophrenia in Spain.
@en
Cost-Minimisation Analysis of ...... nt for Schizophrenia in Spain.
@nl
P2093
P2860
P1476
Cost-Minimisation Analysis of ...... nt for Schizophrenia in Spain.
@en
P2093
Beatriz González
Ignacio Cuervo-Arango
Ignacio García
Miguel Angel Casado
P2860
P304
P356
10.1007/S40261-016-0393-Z
P577
2016-03-21T00:00:00Z